Global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is predicted to grow from US$ 1560 million in 2025 to US$ 2101 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031. Get access now!

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Trends and Opportunities 2025-31

The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is predicted to grow from US$ 1560 million in 2025 to US$ 2101 million in 2031; it is expected to grow at a CAGR of 5.1% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration. Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe. In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%. Infinity Market Research newest research report, the Contrast Agents for Magnetic Resonance Imaging (MRI) Industry Forecast looks at past sales and reviews total world Contrast Agents for Magnetic Resonance Imaging (MRI) sales in 2024, providing a comprehensive analysis by region and market sector of projected Contrast Agents for Magnetic Resonance Imaging (MRI) sales for 2025 through 2031. With Contrast Agents for Magnetic Resonance Imaging (MRI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contrast Agents for Magnetic Resonance Imaging (MRI) industry. This Insight Report provides a comprehensive analysis of the global Contrast Agents for Magnetic Resonance Imaging (MRI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contrast Agents for Magnetic Resonance Imaging (MRI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Contrast Agents for Magnetic Resonance Imaging (MRI) market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contrast Agents for Magnetic Resonance Imaging (MRI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contrast Agents for Magnetic Resonance Imaging (MRI). This report presents a comprehensive overview, market shares, and growth opportunities of Contrast Agents for Magnetic Resonance Imaging (MRI) market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Barium-based Contrast Media &nbsp;&nbsp;&nbsp; Iodinated Contrast Media &nbsp;&nbsp;&nbsp; Gadolinium-based Contrast Media &nbsp;&nbsp;&nbsp; Microbubble Contrast Media Segmentation by Application: &nbsp;&nbsp;&nbsp; Radiology &nbsp;&nbsp;&nbsp; Interventional Radiology &nbsp;&nbsp;&nbsp; Interventional Cardiology This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; GE Healthcare (US) &nbsp;&nbsp;&nbsp; Bracco Imaging (Italy) &nbsp;&nbsp;&nbsp; Bayer HealthCare (Germany) &nbsp;&nbsp;&nbsp; Guerbet (France) &nbsp;&nbsp;&nbsp; Lantheus (US) &nbsp;&nbsp;&nbsp; Daiichi Sankyo (Japan) &nbsp;&nbsp;&nbsp; Unijules Life Sciences (India) &nbsp;&nbsp;&nbsp; J.B. Chemicals and Pharmaceuticals (India) &nbsp;&nbsp;&nbsp; Spago Nanomedicine (Sweden) &nbsp;&nbsp;&nbsp; Taejoon Pharm (South Korea) &nbsp;&nbsp;&nbsp; Jodas (India) &nbsp;&nbsp;&nbsp; Magnus Health (India) Key Questions Addressed in this Report What is the 10-year outlook for the global Contrast Agents for Magnetic Resonance Imaging (MRI) market? What factors are driving Contrast Agents for Magnetic Resonance Imaging (MRI) market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Contrast Agents for Magnetic Resonance Imaging (MRI) market opportunities vary by end market size? How does Contrast Agents for Magnetic Resonance Imaging (MRI) break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Contrast Agents for Magnetic Resonance Imaging (MRI) by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Contrast Agents for Magnetic Resonance Imaging (MRI) by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type &nbsp;2.2.1 Barium-based Contrast Media &nbsp;2.2.2 Iodinated Contrast Media &nbsp;2.2.3 Gadolinium-based Contrast Media &nbsp;2.2.4 Microbubble Contrast Media &nbsp;2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type &nbsp;2.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Type (2020-2025) &nbsp;2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application &nbsp;2.4.1 Radiology &nbsp;2.4.2 Interventional Radiology &nbsp;2.4.3 Interventional Cardiology &nbsp;2.5 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application &nbsp;2.5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Breakdown Data by Company &nbsp;3.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Company (2020-2025) &nbsp;3.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Company &nbsp;3.4 Key Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Product Location Distribution &nbsp;3.4.2 Players Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Contrast Agents for Magnetic Resonance Imaging (MRI) by Geographic Region &nbsp;4.1 World Historic Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth &nbsp;4.4 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth &nbsp;4.5 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth &nbsp;4.6 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth 5 Americas &nbsp;5.1 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country &nbsp;5.1.1 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025) &nbsp;5.1.2 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025) &nbsp;5.2 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2020-2025) &nbsp;5.3 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region &nbsp;6.1.1 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2020-2025) &nbsp;6.1.2 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2020-2025) &nbsp;6.2 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2020-2025) &nbsp;6.3 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) by Country &nbsp;7.1.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025) &nbsp;7.1.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025) &nbsp;7.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2020-2025) &nbsp;7.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) by Country &nbsp;8.1.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) &nbsp;10.3 Manufacturing Process Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) &nbsp;10.4 Industry Chain Structure of Contrast Agents for Magnetic Resonance Imaging (MRI) 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors &nbsp;11.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customer 12 World Forecast Review for Contrast Agents for Magnetic Resonance Imaging (MRI) by Geographic Region &nbsp;12.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Region &nbsp;12.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by Region (2026-2031) &nbsp;12.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by Type (2026-2031) &nbsp;12.7 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 GE Healthcare (US) &nbsp;13.1.1 GE Healthcare (US) Company Information &nbsp;13.1.2 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 GE Healthcare (US) Main Business Overview &nbsp;13.1.5 GE Healthcare (US) Latest Developments &nbsp;13.2 Bracco Imaging (Italy) &nbsp;13.2.1 Bracco Imaging (Italy) Company Information &nbsp;13.2.2 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.2.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Bracco Imaging (Italy) Main Business Overview &nbsp;13.2.5 Bracco Imaging (Italy) Latest Developments &nbsp;13.3 Bayer HealthCare (Germany) &nbsp;13.3.1 Bayer HealthCare (Germany) Company Information &nbsp;13.3.2 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.3.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Bayer HealthCare (Germany) Main Business Overview &nbsp;13.3.5 Bayer HealthCare (Germany) Latest Developments &nbsp;13.4 Guerbet (France) &nbsp;13.4.1 Guerbet (France) Company Information &nbsp;13.4.2 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.4.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Guerbet (France) Main Business Overview &nbsp;13.4.5 Guerbet (France) Latest Developments &nbsp;13.5 Lantheus (US) &nbsp;13.5.1 Lantheus (US) Company Information &nbsp;13.5.2 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.5.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Lantheus (US) Main Business Overview &nbsp;13.5.5 Lantheus (US) Latest Developments &nbsp;13.6 Daiichi Sankyo (Japan) &nbsp;13.6.1 Daiichi Sankyo (Japan) Company Information &nbsp;13.6.2 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.6.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Daiichi Sankyo (Japan) Main Business Overview &nbsp;13.6.5 Daiichi Sankyo (Japan) Latest Developments &nbsp;13.7 Unijules Life Sciences (India) &nbsp;13.7.1 Unijules Life Sciences (India) Company Information &nbsp;13.7.2 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.7.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Unijules Life Sciences (India) Main Business Overview &nbsp;13.7.5 Unijules Life Sciences (India) Latest Developments &nbsp;13.8 J.B. Chemicals and Pharmaceuticals (India) &nbsp;13.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Information &nbsp;13.8.2 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.8.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 J.B. Chemicals and Pharmaceuticals (India) Main Business Overview &nbsp;13.8.5 J.B. Chemicals and Pharmaceuticals (India) Latest Developments &nbsp;13.9 Spago Nanomedicine (Sweden) &nbsp;13.9.1 Spago Nanomedicine (Sweden) Company Information &nbsp;13.9.2 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.9.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Spago Nanomedicine (Sweden) Main Business Overview &nbsp;13.9.5 Spago Nanomedicine (Sweden) Latest Developments &nbsp;13.10 Taejoon Pharm (South Korea) &nbsp;13.10.1 Taejoon Pharm (South Korea) Company Information &nbsp;13.10.2 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.10.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Taejoon Pharm (South Korea) Main Business Overview &nbsp;13.10.5 Taejoon Pharm (South Korea) Latest Developments &nbsp;13.11 Jodas (India) &nbsp;13.11.1 Jodas (India) Company Information &nbsp;13.11.2 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.11.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Jodas (India) Main Business Overview &nbsp;13.11.5 Jodas (India) Latest Developments &nbsp;13.12 Magnus Health (India) &nbsp;13.12.1 Magnus Health (India) Company Information &nbsp;13.12.2 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Portfolios and Specifications &nbsp;13.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.12.4 Magnus Health (India) Main Business Overview &nbsp;13.12.5 Magnus Health (India) Latest Developments 14 Research Findings and Conclusion

Report	Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Growth 2025-2031
Selected License	Single ID:LPI21162

Buyer Information

Order Summary